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Veterinary treatment of cows with
isoxsuprine for a caesarian section
may temporarily lead to residues in hair
of both cow and calf
M. J. Groot,a∗ J. J. P. Lasaroms,a J. Van Hendeb andM.W.F. Nielena,c
Isoxsuprine is a beta-agonist that can be used for growth promotion in cattle, but it is also used as registered veterinary
medicine. To investigate if veterinary treatment of cows could lead to residues of isoxsuprine in thehair of their newborn calves,
an animal experiment was performed. Four cows, treated on veterinary indication with isoxsuprine lactate (Duphaspasmin)
before a caesarian section, were included in the experiment. Hair samples from cows and from their calves were analyzed.
The animals were shaved every week for 16 weeks and levels of isoxsuprine were measured in hair. In the cows, the levels
of isoxsuprine were highest (>15 µg/kg) just after administration of the isoxsuprine lactate. After two weeks in two cows,
a sort of plateau was reached and then the levels decreased. After approximately 10-15 weeks the levels were around
the CCα level of the method used (0.5 µg/kg). In calves, for the first two weeks after birth, no isoxsuprine was found
above CCα level in three of the four animals. At about 20–30 days old, a maximum concentration of 4 µg/kg was found.
Then the levels dropped again under the CCα level, after 60 days no levels above CCα level were found. In one animal,
the levels never reached CCα level. We conclude that veterinary treatment of cows with isoxsuprine may temporarily
lead to low levels of isoxsuprine in the hair of their newborn calves which can be measured for a maximum of 60 days
after birth. Copyright c© 2011 JohnWiley & Sons, Ltd.
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Introduction
Isoxsuprine is a phenylethylamine derivative of epinephrinewhich
has both β-adrenergic agonistic and α-adrenergic antagonistic
properties.[1] In human medicine, isoxsuprine is used as a
vasodilator[2] and tocolytic.[3] In domestic animals, it has been
used to produce uterus relaxation and to perform obstetric
procedures.[4,5] In horses, isoxsuprine hydrochloride is used
for treatment of navicular syndrome and laminitis.[6] In the
Netherlands, isoxsuprine lactate is registered as a veterinary
medicine,Duphaspasmin,andusedforuterus relaxation (tocolysis)
during caesarian section in cows.
Isoxsuprine is a β-agonist and these compounds also have a
history of illegal use as repartitioning agent in cattle,[7] leading to
more leanmuscle, less fat, and reduced feedconversion. In Europe,
the use of β-agonists for growth promotion is forbidden under
the Council Directive 96/22/EC.[8] In the Netherlands, isoxsuprine
is sometimes found in the hair of veal calves during control for
illegal growth promoters. It is not clear if this is the result of
treatment of the mother or the result of illegal treatment for
growth promotion. Residues in the hair of newborn calves were
not investigated in the registration process of Duphaspamin as a
veterinary medicine. Therefore calves derived from isoxsuprine-
lactate-treated cows were followed in time, as well as the
cows. The aim of this investigation was to gain an insight into
the kinetics of isoxsuprine in hair and to get information on
the detection window of isoxsuprine in hair from untreated
calves.
Material andMethods
Experimental, veterinary treatment, and sampling
The experimentwas performed in cooperationwith the Veterinary
Faculty of Ghent University (Belgium) on a nearby farm. For this
experiment, four cows (black-and-white Holstein Friesians) were
used that were veterinary treated with Duphaspasmin, (REG NL
8514, isoxsuprine lactate 11.58 mg/ml, Fort Dodge Animal Health
Benelux B.V. Naarden, Netherlands) for a caesarian section. Calves
were separated from the cows (three male calves and one female)
after birth according to dairy practice and were fed colostrum
from the freezer containing no isoxsuprine. Both cows and calves
were sampled weekly for hair, starting with the day of birth of the
calves. Hair was shaved from the back and the sides of the animals,
left and right side alternately each week. The samples consisted
of black hair mixed with white hair. The animals were followed for
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16 weeks. First the hair was cut with a scalpel as close as possible
to the bare skin. Later a shaving machine was used and only dry
hair was sampled.
Analytical methods
Chemicals
The chemicals and solutionsusedwereof analytical reagentgrade.
Water was purified using a Milli-Q system fromMillipore (Bedford,
MA, USA). Isoxsuprine was obtained from Sigma (St Louis, MO,
USA). The isotope-labelled internal standard clenbuterol-d6 was
obtained from RIVM (Bilthoven, the Netherlands). Stock solutions
were prepared in methanol at 1 mg/ml. Bondelut Certify mixed-
mode solid-phase extraction (SPE) columns (300 mg) were from
Varian (Harbor City, CA, USA).
Hair
Hair sampleswere cutwith apair of scissors to less than 2 cm. From
each sample two test portions of 500 mgwere weighed. Both test
portions were spiked with the internal standard clenbuterol-d6
at 10 ng/g. In addition, one of these portions was spiked with
isoxsuprine at 5 ng/g.
Blanks and controls were spiked with the internal standard
clenbuterol-d6 at 10 ng/g. The control hair sampleswere prepared
by spiking blank hair with isoxsuprine at 0, 2.5, 5.0, 10, 20, and
50 ng/g. Following the addition of 4 ml NaOH (1.0 M) solution,
digestion was carried out in a water bath at 65◦ for 2 h. Next,
3.5 ml of HCL (1.0 M) and 5 ml of 0.25 M sodium acetate buffer pH
4.8 were added and the test tubes were centrifuged for 10 min
at 2000 g. The supernatants were transferred to a clean test tube,
adjusted to pH4.8 if necessary, and centrifuged again for 10 min at
2000 g. The supernatants thus obtained were further subjected to
solid phase extraction (SPE) on a mixed-mode column, previously
conditionedbymethanol and sodiumacetate buffer. The vacuum-
dried SPE column was washed subsequently with 1 ml of 1M
acetic acid, 6 ml of methanol and 2 ml of acetone/chloroform
(1 : 1). Finally the contents of the dried SPE column were eluted
with 7.5 ml of 1% ammonia in ethyl acetate and the eluate was
evaporated to dryness under a stream of nitrogen gas at 40 ◦C.
The residue obtained was redissolved in 300 µL of 0.24% formic
acid. 50 µl was injected into the liquid chromatography-tandem
mass spectrometry (LC-MS/MS) system.
LC-MS/MS
The LC-MS/MS system consisted of a Shimadzu (Milford, MA,
USA) model LC system equipped with a Waters (Manchester,
UK) model Quattro Ultima triple-quadrupole mass spectrometer.
The mass spectrometer was operated in the positive electrospray
ionization (ESI) mode at a capillary voltage of 2.7 kV, a desolvation
temperature of 300◦, a source temperature of 120◦ and a cone
voltageof 35 V. Thedesolvationgaswasnitrogenand thecollision-
induceddissociation (CID)gaswasargon. For isoxsuprine, themost
abundant multiple reactionmonitoring (MRM) transition (used for
the quantification) was acquired using the following conditions:
precursor ion mass (m/z) 302.1, product ion mass (m/z) 135.0 with
a Collision energy of 20 (eV). A second MRM transition, used for
the confirmation of the identity of isoxsuprine, was acquired using
the following conditions: precursor ion mass (m/z) 302.1, Product
ion mass (m/z) 150.0 with a Collision energy of 20 (eV).
Theanalytical columnwasa150 mm×3.2 mminternaldiameter
5-µmC18Alltima column (Alltech, Breda, the Netherlands), kept in
a column oven at 40◦. The two mobile phases used consisted
of 100 : 0.1 water/formic acid (v/v) (solvent A) and 100 : 0.1
acetonitrile/formic acid (v/v) (solvent B) and the flow rate was
0.4 ml/min. Following a 1-min isocratic period at 0% solvent B,
a linear gradient was started towards 60% solvent B at 8 min,
and up to 100% solvent B at 9 min. The liquid chromatograph
was connected to the ESI-MS/MS instrument using a 1 : 2 split.
The concentrations of isoxsuprine in hair samples were estimated
using the isotope dilution method and a standard addition of
5 ng/g isoxsuprine to each individual sample.
Results and Discussion
During the experimental period, the animals remainedon the farm
where they were born and were shaved weekly. All four calves
and their mothers were followed for four months and no health
problems were observed in the experimental period in either the
cows or the newborn calves.
Weekly samples of hair per animal were received. The cow
samples (encoded3377, 4976, 4982, and4999) and their respective
calves (encoded 7568, 7569, 7570, and 7572) were analyzed for
isoxsuprine. The results of both cows and their calves are shown
in Figure 1.
On the left, you see the levels isoxsuprine in the hair samples
from the cows and on the right, the levels in the hair samples from
their calves. The level of isoxsuprine in the hair samples from the
cows was highest just after administration of the drug, reaching
levels >15 µg/kg, with 50 µg/kg as highest level found. After two
weeks, two cows reached a sort of plateau level and after 50 days
the levels dropped. In two other cows however, additional peaks
were observed at 80–90 days after treatment (animals 4976 and
3377). After approximately 10–15 weeks, all levels were around or
below the CCα level of the method used (0.5 µg/kg).
In the hair samples from their calves, in the first two weeks
after birth no isoxsuprine was found above CCα level. At about
20–30 days of age a maximum concentration of 2.5–4 µg/kg was
found in three of four calves. Then the levels dropped again under
the CCα level and after 60 days no levels above CCα level were
found anymore. In one animal (7568) the levels of isoxsuprine
in hair never reached the CCα level during the whole sampling
period.
In this experiment, levels of isoxsuprine in hair samples from
cows treated with isoxsuprine lactate for a caesarian section and
levels of isoxsuprine in hair samples from their newborn calves
were followed for 16 weeks. Isoxsuprine was found in hair of both
cow and calf.
The detection of β-agonists in hair is performed since 1994.[9]
Analysis of isoxsuprine in hair and urine is described more
recently.[10,11] There are several ways in which drugs can enter
the hair, such as passive diffusion from the blood stream into the
growing cells at the base of the hair follicle, or binding of the drug
tomelanin or to sulfhydryl-containing amino acids such as cystine
in hair. Another possibility is diffusion of the drug along the hair
shaft transferred from sweat and sebum.[12]
The excretion of isoxsuprine in the cows’ hair was remarkably
fast after administration of this drug. This implies that isoxsuprine
is excreted via sweat or sebaceous glands, since hair growthwould
require severalweeks to appear above the skin. Another possibility
is that hair was contaminated by the injection fluid, but that is
www.drugtestinganalysis.com Copyright c© 2011 John Wiley & Sons, Ltd. Drug Test. Analysis (2011)
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Figure 1. Levels of isoxsuprine in hair: cows left and their calves on the right side.
not likely because the operation site had been shaved already
and the hair was also sampled at other sites. The peaks following
the first peak might be due to isoxsuprine that reached the hair
via the blood stream or bound to pigments in the hair. In horses,
prolonged excretion (up to six weeks) of isoxsuprine in urine is
found after cessation of treatment. Melanin affinity of isoxsuprine
in the horse is suggested as a possible mechanism to explain this
finding.[13] A similar mechanism may be present in cows leading
to prolonged levels in hair (80–100 days after treatment) as is seen
in cows 4976 and 3377. The hair samples in our experiment were
not selected for white or black hair and all samples were mixed.
In future experiments we aim to differentiate the samples into all
black, all white, andmixed hair samples to investigate the possible
effect of binding of the drug to melanin.
In the calves, the first isoxsuprine was seen in the hair after
3–4 weeks which may be due to passive diffusion from the blood.
Differences between the levels of isoxsuprine in the calves may
be explained by the natural variation in physiology between the
animals and differences in the times necessary to deliver the
calves after treatment of the mother. The calves did not receive
isoxsuprine via themilk since theygot colostrum fromnon-treated
cows and also in the following period they did not receive milk
from treated animals. On this farm, itwas commonpractice to feed
newborn calves with colostrum from the freezer and not from
their ownmother as is usually done. For our study, this meant that
the only route of isoxsuprine for the calves was via the mother
during the partus. Milk from the treated cows was not analyzed
for isoxsuprine.
Since a withdrawal time of 5 days for cows’ milk is required after
treatment with Duphaspasmin, themilk from treated cows cannot
be used for human consumption. In practice this milk is fed to the
calves which may lead to additional exposure to isoxsuprine. In
conventional dairy farming,most calves are fedmilk-replacer after
the first three days of life, and if extramilk is added itwill be diluted
with milk replacer and water. It is not clear if these levels influence
the levelsof isoxsuprine inhair.Calves intendedforvealproduction
are sold after 10 days of birth so it is only in the first weeks of
their lives that they may have got additional isoxsuprine, levels of
which would be very low. In our calves, the highest levels were
seen between 20 and 40 days after birth. Additional isoxsuprine
via the milk may possibly cause the excretion period to be a week
or two longer. But in that case there is no veterinary indication
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for treatment, so this kind of administration of isoxsuprine can be
considered as illegal treatment.
No data about uptake of oral isoxsuprine in calves are available.
To evaluate the possible contribution of isoxsuprine in milk from
treated cows to levels in the calves’ hair, another experiment
should be performed, one which was beyond the scope of
this study. In healthy human volunteers, the absorption of
isoxsuprine was assumed to be about 51%,[14] and for horses,
oral bioavailability was found to be 2.2% with a high first-pass
effect.[6] However, caesarian sections are not very common on
Dutch dairy farms although one study mentioned percentages
per farm ranging from 0 to 3.6%.[15] Based on this, findings of
isoxsuprine in calves’ hair should be rare, if found at all.
The New Food and Consumer Product Safety Authority in
the Netherlands may control hair samples from veal calves at
any age, thus also from animals from 0–10 weeks. During these
inspections, hair positive for isoxsuprine has been found in young
calves. These findings were the reason this study was performed.
The results of our experiment provide important information that
may help prevent unnecessary prosecution of farmers due to the
inadvertent presence of banned substances in hair samples from
their animals.
In the Netherlands, isoxsuprine is the only beta-agonist
registered as a veterinary medicine for cows. Planipart REG NL
7068, containing clenbuterol hydrochloride, was also registered as
tocolyticum for cows but hasn’t been registered since 2009. There
are other clenbuterol containing veterinary medicines but these
are only registered for horses.
Other veterinary medicines that might lead to residues in hair
are esters of steroid hormones, such as estrogens, gestagens,
and androgens. But in practice there are no indications to treat
pregnant cattle with these hormones.
Conclusion
We can conclude from this experiment that veterinary treatment
of cows with isoxsuprine for a caesarian section may temporarily
lead to residues in hair of both cow and calf. Low levels of
isoxsuprine in calves’ hair during the first two months of their
lives can be caused by veterinary treatment of their mother with
isoxsuprine lactate. Levels higher than 4 µg/kg in calves under two
months and levels above CCα (0.5 µg/kg) in older calves may be
suspect for illegal treatment for growth promotion. In these cases,
further action is required. In case of doubt, records for veterinary
treatment of the calf’s mother should be consulted as well as
information on the use of isoxsuprine contaminated milk to feed
the calves.
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